- In March 2023, Nevada Zinc Corporation announced the successful production of high-quality zinc sulfate monohydrate at its pilot plant facility, which marked a significant progression from its initial small-scale trial started in March 2021. This milestone strengthens the company's position in the specialty zinc chemical market and showcases its ability to scale operations for commercial viability
- In September 2022, Redox obtained the FAMI-QS certification from DNV Business Assurance Australia Pty Limited, highlighting its compliance with global quality and safety standards for feed additives and pre-mixtures. This achievement enhances Redox’s reputation as a reliable supplier of high-quality zinc sulfate in the animal feed industry
- In August 2022, Piramal Pharma’s Critical Care division introduced the first-ever generic Zinc Sulfate Injection in the U.S. market, expanding access to this essential supplement for zinc-deficient patients in hospital settings. The launch supports affordability and availability of zinc-based therapeutics in critical care
- In January 2020, American Regent launched Zinc Sulfate Injection, intended as a trace element for adult and pediatric patients requiring parenteral nutrition due to the lack or inadequacy of oral or enteral intake. This release broadened clinical options for zinc supplementation in medical nutrition therapies
